Alexis B Cortot

Alexis B Cortot

UNVERIFIED PROFILE

Are you Alexis B Cortot?   Register this Author

Register author
Alexis B Cortot

Alexis B Cortot

Publications by authors named "Alexis B Cortot"

Are you Alexis B Cortot?   Register this Author

36Publications

1255Reads

14Profile Views

Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice.

Clin Lung Cancer 2019 Jul 26;20(4):297-304.e1. Epub 2019 Feb 26.

Thoracic Oncology Department, Univ. Lille CHU Lille, Lille, France; UMR 8161 M3T Mechanisms of Tumorigenesis and Targeted Therapies, Univ. Lille CNRS Institut Pasteur de Lille, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.02.013DOI Listing
July 2019

Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients.

J Thorac Oncol 2018 12 7;13(12):1873-1883. Epub 2018 Sep 7.

Lille University, CNRS, Institut Pasteur de Lille, Mechanisms of Tumorigenesis and Targeted Therapies, Lille, France; Lille University, Thoracic Oncology Department, CHU Lille, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.08.2023DOI Listing
December 2018

Current and Former Smokers: Who Wants To Be Screened?

Clin Lung Cancer 2018 11 6;19(6):493-501. Epub 2018 Jul 6.

Department of Respiratory Diseases and Thoracic Oncology, Hôpital Calmette, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.07.001DOI Listing
November 2018

MET amplification increases the metastatic spread of EGFR-mutated NSCLC.

Lung Cancer 2018 11 11;125:57-67. Epub 2018 Sep 11.

Thoracic Oncology Department, CHU Lille, Siric OncoLille, F-59000, Lille, France; Univ Lille, Lille, France; Univ. Lille, CNRS, Institut Pasteur de Lille, UMR 8161 - M3T - Mechanisms of Tumorigenesis and Targeted Therapies, F-59000, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183056
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.09.008DOI Listing
November 2018

The multiple paths towards MET receptor addiction in cancer.

Oncogene 2018 06 19;37(24):3200-3215. Epub 2018 Mar 19.

Univ. Lille, CNRS, Institut Pasteur de Lille, UMR 8161 - M3T - Mechanisms of Tumorigenesis and Targeted Therapies, F-59000, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0185-4DOI Listing
June 2018

Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey.

Prev Med Rep 2018 Jun 18;10:332-336. Epub 2018 Apr 18.

Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations, Chemin des Bourrely, 13915 Marseille Cedex 20, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pmedr.2018.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984220PMC
June 2018

Perception of Lung Cancer Risk: Impact of Smoking Status and Nicotine Dependence.

Curr Oncol Rep 2018 03 5;20(Suppl 1):18. Epub 2018 Mar 5.

Service de Pneumologie Aiguë Spécialisée et Cancérologie Thoracique, Centre Hospitalier Lyon Sud, 165 chemin du Grand Revoyet, 69495, Pierre Bénite Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0650-1DOI Listing
March 2018

Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study.

BMC Cancer 2018 02 13;18(1):178. Epub 2018 Feb 13.

CHU Lille, Department of Respiratory Diseases, MESOCLIN, Center for Infection and Immunity of Lille (INSERM U1019 - UMR 8204 - Pasteur Institute of Lille), University of Lille, F-59000, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4102-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810120PMC
February 2018

Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers.

J Natl Cancer Inst 2017 05;109(5)

UMR 8161 - M3T - Mechanisms of Tumorigenesis and Targeted Therapies, CNRS, Institut Pasteur de Lille, Univ. Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw262DOI Listing
May 2017

Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non-Small Cell Lung Carcinomas.

Am J Surg Pathol 2017 Mar;41(3):414-422

*Institute of Pathology, Avenue Oscar Lambret, CHU Lille †CNRS, Institute Pasteur of Lille, UMR 8161-M3T-Mechanisms of Tumorigenesis and Target Therapies ‡Thoracic Oncology Department, Avenue Oscar Lambret, CHU Lille, Univ. Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000810DOI Listing
March 2017

[Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys].

Bull Cancer 2017 Mar 18;104(3):258-266. Epub 2017 Jan 18.

CHRU de Tours, centre de coordination des dépistages des cancers, 37044 Tours cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.12.002DOI Listing
March 2017

High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble form.

Lung Cancer 2016 11 14;101:59-67. Epub 2016 Sep 14.

Univ. Lille, CNRS, Institut Pasteur de Lille, UMR 8161 - M3T - Mechanisms of Tumorigenesis and Targeted Therapies, F-59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.009DOI Listing
November 2016

[Osimertinib (Tagrisso): Activity, indication and modality of use in non-small cell lung cancer].

Bull Cancer 2016 Oct 15;103(10):815-821. Epub 2016 Sep 15.

AP-HP, hôpital Tenon, service de pneumologie, 4, rue de la Chine, 75020 Paris, France; Sorbonne universités, UPMC université Paris 06, GRC n(o) 04, Theranoscan, 75252 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.06.007DOI Listing
October 2016

Afatinib + Cetuximab First-line in EGFR-Mutant Lung Cancer--Letter.

Clin Cancer Res 2016 Apr;22(7):1827

AP-HP Hôpital Tenon, Chest Department-GRC-04 Theranoscan P&M Curie University Paris 6, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2824DOI Listing
April 2016

PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.

Mol Oncol 2015 Nov 15;9(9):1852-67. Epub 2015 Jul 15.

CNRS UMR 8161, Institut de Biologie de Lille, Institut Pasteur de Lille, Université de Lille, SIRIC ONCOLille, Lille 59021, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.07.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528715PMC
November 2015

ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?

Expert Rev Anticancer Ther 2015 Feb 21;15(2):225-33. Epub 2014 Nov 21.

Department of Respiratory Medicine and Thoracic Oncology, Hôpital Louis Pradel, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.2014.98
Publisher Site
http://dx.doi.org/10.1586/14737140.2014.986103DOI Listing
February 2015

Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas.

Eur Respir Rev 2014 Sep;23(133):356-66

Thoracic Oncology Dept, Hopital Calmette, Lille University Hospital, Université Lille Nord de France, Lille, France. UMR8161, Institut de Biologie de Lille, Siric OncoLille, Universités Lille 1, Lille, France. Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09059180.00004614DOI Listing
September 2014

[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?].

Bull Cancer 2014 Sep;101(9):823-31

AP-HP Marseille, Université Aix-Marseille, Service d'oncologie multidisciplinaire & innovations thérapeutiques, 13015 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2014.1976DOI Listing
September 2014

Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas.

Clin Lung Cancer 2014 Mar 26;15(2):124-30. Epub 2013 Oct 26.

Department of Translational Research, Institut Gustave Roussy, Villejuif, France; INSERM Unit 981, University Paris-South, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2013.08.003DOI Listing
March 2014

Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer.

Eur Respir J 2013 Nov 21;42(5):1357-64. Epub 2013 Mar 21.

Lille University Hospital (CHRU), Lille.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09031936.00086712DOI Listing
November 2013

Resistance to irreversible EGF receptor tyrosine kinase inhibitors through a multistep mechanism involving the IGF1R pathway.

Cancer Res 2013 Jan 19;73(2):834-43. Epub 2012 Nov 19.

Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-12-2066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994895PMC
January 2013

KRAS mutation status in primary nonsmall cell lung cancer and matched metastases.

Cancer 2010 Jun;116(11):2682-7

Department of Pulmonary Diseases, Lyon Sud Hospital Center, Claude Bernard University, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25014DOI Listing
June 2010

Histology... For want of anything better?

Oncology (Williston Park) 2009 Nov;23(13):1140-1

Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
November 2009